225 related articles for article (PubMed ID: 17599817)
1. The renal clearance of dextran sulfate decreases in puromycin aminonucleoside-induced glomerulosclerosis: a puzzle observation.
Santos AM; Pomin VH; Stelling MP; Guimarães MA; Cardoso LR; Mourão PA
Clin Chim Acta; 2007 Aug; 383(1-2):116-25. PubMed ID: 17599817
[TBL] [Abstract][Full Text] [Related]
2. Glomerular sclerosis in nephrotic rats. Comparison of the long-term effects of adriamycin and aminonucleoside.
Grond J; Weening JJ; Elema JD
Lab Invest; 1984 Sep; 51(3):277-85. PubMed ID: 6471809
[TBL] [Abstract][Full Text] [Related]
3. Glomerular basement membrane heparan sulfate glycosaminoglycan in aminonucleoside of puromycin nephrosis.
Garin EH; Shirey AJ
Child Nephrol Urol; 1988-1989; 9(3):121-6. PubMed ID: 2978121
[TBL] [Abstract][Full Text] [Related]
4. Podocyte architecture in puromycin aminonucleoside-treated rats administered tungsten or allopurinol.
Ricardo SD; Bertram JF; Ryan GB
Exp Nephrol; 1995; 3(5):270-9. PubMed ID: 7583048
[TBL] [Abstract][Full Text] [Related]
5. Alterations in the charge and size selectivity barrier of the glomerular filter in aminonucleoside nephrosis in rats.
Olson JL; Rennke HG; Venkatachalam MA
Lab Invest; 1981 Mar; 44(3):271-9. PubMed ID: 7464051
[TBL] [Abstract][Full Text] [Related]
6. Altered expression of NDST-1 messenger RNA in puromycin aminonucleoside nephrosis.
Nakayama K; Natori Y; Sato T; Kimura T; Sugiura A; Sato H; Saito T; Ito S; Natori Y
J Lab Clin Med; 2004 Feb; 143(2):106-14. PubMed ID: 14966466
[TBL] [Abstract][Full Text] [Related]
7. Unilateral renal disease in the rat. I. Clinical, morphologic, and glomerular mesangial functional features of the experimental model produced by renal perfusion with aminonucleoside.
Hoyer JR; Mauer SM; Michael AF
J Lab Clin Med; 1975 May; 85(5):756-68. PubMed ID: 1091713
[TBL] [Abstract][Full Text] [Related]
8. Ameliorative effects of dietary protein restriction in chronic aminonucleoside nephrosis.
Diamond JR; Karnovsky MJ
J Lab Clin Med; 1987 May; 109(5):538-44. PubMed ID: 3572200
[TBL] [Abstract][Full Text] [Related]
9. Temocapril, a long-acting non-SH group angiotensin converting enzyme inhibitor, modulates glomerular injury in chronic puromycin aminonucleoside nephrosis.
Zheng Y; Shirato I; Maeda A; Kobayashi N; Liao J; Shou I; Fukui M; Tomino Y
J Nephrol; 2002; 15(1):36-41. PubMed ID: 11936424
[TBL] [Abstract][Full Text] [Related]
10. Glomerular processing of dextran sulfate during transcapillary transport.
Vyas SV; Burne MJ; Pratt LM; Comper WD
Arch Biochem Biophys; 1996 Aug; 332(2):205-12. PubMed ID: 8806727
[TBL] [Abstract][Full Text] [Related]
11. Protective effects of antithrombin on puromycin aminonucleoside nephrosis in rats.
Yamashita J; Nakajima K; Ohno Y; Kaneshiro Y; Matsuo T; Tanaka H; Kaneko K
Eur J Pharmacol; 2008 Jul; 589(1-3):239-44. PubMed ID: 18541230
[TBL] [Abstract][Full Text] [Related]
12. Beneficial effects of orosomucoid on the glomerular barrier in puromycin aminonucleoside-induced nephrosis.
Hjalmarsson C; Lidell ME; Haraldsson B
Nephrol Dial Transplant; 2006 May; 21(5):1223-30. PubMed ID: 16410268
[TBL] [Abstract][Full Text] [Related]
13. Urinary kallikrein in experimental renal disease.
Glasser RJ; Michael AF
Lab Invest; 1976 Jun; 34(6):616-22. PubMed ID: 933467
[TBL] [Abstract][Full Text] [Related]
14. Experimental model of focal sclerosis. I. Relationship to protein excretion in aminonucleoside nephrosis.
Glasser RJ; Velosa JA; Michael AF
Lab Invest; 1977 May; 36(5):519-26. PubMed ID: 865079
[TBL] [Abstract][Full Text] [Related]
15. Renal purine efflux and xanthine oxidase activity during experimental nephrosis in rats: difference between puromycin aminonucleoside and adriamycin nephrosis.
Ginevri F; Gusmano R; Oleggini R; Acerbo S; Bertelli R; Perfumo F; Cercignani G; Allegrini S; D'Allegri F; Ghiggeri G
Clin Sci (Lond); 1990 Mar; 78(3):283-93. PubMed ID: 2156648
[TBL] [Abstract][Full Text] [Related]
16. Ultrastructural study on nephrin expression in experimental puromycin aminonucleoside nephrosis.
Lee YK; Kwon T; Kim DJ; Huh W; Kim YG; Oh HY; Kawachi H
Nephrol Dial Transplant; 2004 Dec; 19(12):2981-6. PubMed ID: 15385636
[TBL] [Abstract][Full Text] [Related]
17. In situ hybridization of type I collagen mRNA in puromycin aminonucleoside-induced glomerulosclerosis.
Osada S; Ebihara I; Nakamura T; Fukui M; Tomino Y; Koide H
Exp Nephrol; 1995; 3(1):40-8. PubMed ID: 7712142
[TBL] [Abstract][Full Text] [Related]
18. Furosemide disposition in normal and proteinuric rats: urinary drug-protein binding as a determinant of drug excretion.
Green TP; Mirkin BL
J Pharmacol Exp Ther; 1981 Jul; 218(1):122-7. PubMed ID: 7241373
[TBL] [Abstract][Full Text] [Related]
19. Increased glomerular and extracellular malondialdehyde levels in patients and rats with focal segmental glomerulosclerosis.
Kuo HT; Kuo MC; Chiu YW; Chang JM; Guh JY; Chen HC
Eur J Clin Invest; 2005 Apr; 35(4):245-50. PubMed ID: 15816993
[TBL] [Abstract][Full Text] [Related]
20. Morphologic, molecular and hemodynamic cardiac alterations in a model of nephropathy induced by puromycin aminonucleoside.
Moreira-Rodrigues M; Roncon-Albuquerque R; Henriques-Coelho T; Sampaio-Maia B; Leite-Moreira A; Pestana M
Rev Port Cardiol; 2006 May; 25(5):509-18. PubMed ID: 16910158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
